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Abstract
Background: An evaluation study was carried out to determine the feasibility of integrating the Adolescent Diabetes
Needs Assessment Tool (ADNAT) App into UK paediatric diabetes care, to ascertain best practice standards and to
determine methodological recommendations for a future cohort study.
Methods: A non-randomised, cohort, mixed methods study design was used to ensure equality of access to ADNAT
for all participants at three sites in the North West of England. Following UK Medical Research Council guidance, the
RE-AIM (reach, effectiveness (potential and perceived), adoption, implementation, maintenance) framework was used
to guide study objectives and feasibility outcomes. Patients who completed ADNAT (completers) were compared with
those who failed to complete (non-completers). Patients’ glycaemic control (HbA1c) was accessed from their clinical
data at baseline and at 6 months, alongside their ADNAT scores which were correlated with changes in HbA1c levels.
The diabetes teams (respondents) completed a web-based survey and attended focus group interviews.
Results: Eighty-nine patients were recruited. Withdrawal rates were low at 4.5% (n = 4). Forty-four patients (49.4%)
completed ADNAT, leaving 45 (50.6%) non-completers. There were large baseline differences in HbA1c and variable
rates of change at 6 months. After adjusting for baseline HbA1C and site in an analysis of covariance, completers had
a lower post-ADNAT mean HbA1C level than non-completers at 6 months (-5.42 mmol/mol, 95% CI −11.48, 0.64).
Patients’ glycaemic control (HbA1c) at 6 months correlated reasonably well with their ADNAT scores (Spearman’s
rho = 0.46). Survey and focus group data showed that ADNAT was judged to be an effective clinical tool by
the diabetes teams. Value to patients was perceived by the teams to be linked to parental support, age and
previous diabetes education. The combined data triangulated. It served to capture different dimensions which
were used to define changes to achieve practice standards and methodological recommendations.
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Conclusions: The combined data showed that ADNAT has the potential to be a clinically viable tool. It has
demonstrated the need for a randomised design that is tailored for a ‘hard to reach’ adolescent population. A cluster
randomised controlled trial that involves sequential but random rollout of ADNAT over multiple time periods may be
the most appropriate and is currently being considered for the larger study.
Trial registration: NIHR Children’s Clinical Research Network, UKCRN ID 6633
Keywords: Evaluation, Type 1 diabetes, Needs assessment, Questionnaire, Patient education, Glycaemic control, App
Introduction
This paper reports on a study which evaluated the feasibil-
ity of using the Adolescent Diabetes Needs Assessment
Tool (ADNAT) App in three Paediatric Diabetes Units
(PDUs) in the North West of England. The study used a
realist evaluation approach [1] to address two issues:
firstly, whether the ADNAT App could be integrated into
paediatric diabetes care and, secondly, to determine best
practice standards and methodological recommendations
for a future cohort study. A core assumption of a realist
perspective is that phenomena such as ADNAT are com-
plex interventions introduced into constantly changing
systems, which has particular relevance to paediatric dia-
betes care in the UK. Comparisons within and between
clinical sites were therefore required to determine what
did and did not work and why, in order to establish local
modifications necessary to ensure effectiveness in practice.
This relationship is expressed in Medical Research Coun-
cil (MRC) guidance [2] for process evaluation of complex
interventions which defines evaluation of context, imple-
mentation and mechanisms of implementation as the pri-
mary aims of such studies.
Background
Type 1 diabetes (T1D) is one of the most common endo-
crine and metabolic conditions in childhood within Europe.
The UK, which has 27,600 children and young people living
with the condition, alongside the Russian Federation and
Germany, makes the largest contribution to the overall
numbers in T1D in young people with an incidence rate of
25.9 per 100,000 of the general population aged 0–15 years
and a prevalence rate of 195.4 per 100,000 [3, 4]. Alongside
this, young people in the UK also have one of the worst
rates of glycaemic control in Europe, which is associated
with later micro- and macrovascular risk [5]. This has been
demonstrated in successive National Paediatric Diabetes
Audits (NPDA) for England and Wales for those aged
0–25 years, with the latest for 2015–2016 [4] reporting
improving but still disturbing figures alongside the
need to reduce variability in outcomes:
 Only 26.6% achieved recommended glycaemic targets
of less than 58 mmol/mol, with 17.9% having levels
above 80 putting them at high risk of complications.
 Glycaemic variability is due to service related factors,
including standards and delivery of diabetes self-care
education which showed wide Paediatric Diabetes
Unit (PDU) level variability with 30% receiving no
structured education.
 For those aged 12 years and over: 26.3% had high
blood pressure, 19.7% had high total cholesterol,
9.7% had albuminuria (sign of kidney disease), over
13.8% had early signs of eye disease, and 18.1% were
overweight and 20.8% were obese.
 Overall, just 35.5% of children and young people
received all seven of the recommended key care
processes including blood glucose (HbA1c), body
mass index, blood pressure, urinary albumin,
cholesterol, eye screening and foot examination.
 In general, those in the most deprived areas, were of
non-white ethnicity, were adolescent, or female had
poorer outcomes.
These findings have been supported by the UK’s Na-
tional Peer Review Programme [6] which highlighted in-
equity of service provision to young people. They also fit
with the UK’s Kennedy Review [7] which described teen-
agers as a ‘forgotten group’, reporting that their health
care needs are given low priority by commissioners, pol-
icymakers and clinicians alike, and recommended invest-
ment in youth friendly services. This is particularly
important since many adolescents lack the skills and
strategies to avoid behaviours that carry health risks
which has specific relevance to those with diabetes given
their added risk of future debilitating complications.
In 2012, the UK government responded to the prob-
lem by introducing a paediatric diabetes ‘Best Practice
Tariff ’ (BPT) which defines 13 mandatory care standards
including tailored education [8]. For adults, over a 10-
year period, such education has been shown to save the
National Health Service (NHS) £2200 per patient, break-
ing even at 4 years [9, 10]. No such data are available for
young people, although Swift [11] reported that educa-
tion for young people has greater effects than for adults
with small to medium effects on glycaemic control and
larger effects on psychosocial outcomes.
Given these changes, instigated by the BPT, alongside
the annual National Paediatric Diabetes Audit [4], and a
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Peer Review Quality Assurance Programme [6], paediat-
ric diabetes clinical practice was undergoing extensive
changes. These emerging changes meant that ‘routine
care’ was neither standardised nor constant at the time
of the study so that the outcomes of using ADNAT
depended upon clinical context and health professionals’
responses to its implementation, making the setting a
mediator of outcomes.
In the UK, six paediatric educational trial interventions
have been completed [12–16]. They all followed trad-
itional didactic face-to-face approaches, reported consid-
erable variations in outcomes, and no significant long-
term changes in glycaemic control. Recommendations
included the need to review research methodology and
to modernise paediatric care through the use of technol-
ogy enhanced learning (TEL) to support long-term pa-
tient training. This latter recommendation is supported
by a review of technology enabled approaches to dia-
betes management which endorsed self-assessment tools
and tailored education based on patients’ unique histor-
ies and their immediate needs [17]. In support of this, a
meta-analysis of 46 studies found that a blend of TEL
and face-to-face instruction had stronger learning out-
comes than did face-to-face instruction alone in pri-
mary/secondary/tertiary education [18]. However, there
are few validated diabetes websites for young people, the
majority being directed toward adults; there is wide vari-
ation in the quality of evidence provided, and they offer
didactic information at high reading levels with little
problem-solving assistance [19, 20]. Social networking,
as a patient-led tool, is growing in popularity and start-
ing to be used by patients and practitioners but research
in children with T1D in all these areas is lacking, both in
terms of quantity and quality, reflecting the complex is-
sues of using social media as a clinical tool [21]. System-
atic reviews [22, 23], including our own [24], have
consistently highlighted an absence of rigorous UK-
based research, minimal use of theory and no reporting
of process, health inequalities, dose response and cost-
effectiveness data. In addition, findings highlighted the
need to personalise learning in alignment with develop-
mental stages, i.e. age-related reasoning and cognitive
abilities, making regular needs assessment a core re-
quirement. No instrument to assess such needs was lo-
cated in the UK. We therefore developed, validated and
psychometrically tested the ADNAT App. The App pro-
vides secure username and password protected access to
ADNAT through mobile devices, e.g. smart phones and
tablets, delivers immediate feedback to users and emails
confidential patient data to practitioners.
The ADNAT App
Development, validation and psychometric testing of
ADNAT have been reported elsewhere [25–27]. The
research programme, followed Medical Research Council
(MRC) guidance for complex interventions [28]. It has
included studies of adolescent diabetes self-care [29–31]
and technological methods of learning [24] and theory
[32]. ADNAT combines reflective questioning with needs
assessment to raise self-awareness to support adolescent
decision-making in relation to diabetes self-care. It con-
sists of 117 questions divided between six domains
including all about me, physical activity, eating, monitor-
ing blood glucose, medication taking and living with dia-
betes. The number of questions answered by users is
filtered according to, for example, insulin regimen and
lifestyle factors. Thirty-six of the questions, hidden
amongst the total, provide self-care and psychosocial
health scores Needs Assessment Ratings (NARs) (the
self-care questions with examples of some of the shorter
range of responses are shown later in Table 6). Classical
test theory and item response analysis validated the use
of simple additive scores which we translated into traffic
light responses. Scoring for each item was 0 for green, 1
for amber and 2 for red responses, so that high scores
indicated high need, moderate scores intermediate need
and low scores low need.
From our previous research which qualitatively ana-
lysed the perceptions of the clinical usefulness of
ADNAT with young people, parents and health profes-
sionals [26], ADNAT was theoretically determined to
have the following mechanisms of action:
1. Mediator for facilitating tailored education and
support by raising patients’ self-awareness about
their diabetes self-care and coping mechanisms,
identifying patient-led foci for conversation in the
clinical consultation and providing practitioners and
patients with data to guide individual health care
planning.
2. Augmenting resource efficiency through flexibility of
access for patients and practitioners using mobile
phones and tablets, auto-saving function for ease of
use by patients, large data storage capacity and
provision of ‘connected information’ for all members
of the multidisciplinary team including patients.
3. Strengthening professional accountability through
standardisation of needs assessment, promotion of
team working and provision of educational audit
data.
Based on these premises, ADNAT was included in the
UK National Paediatric Diabetes Improvement Plan for
2013–2018 [33]. This inclusion stipulated the need to
evaluate ADNAT’s use in clinical practice prior to long-
term implementation for which we proposed to follow
MRC’s guidance for process evaluation of complex inter-
ventions [2] to support its on-going development. This
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guidance identifies three areas for evaluation which are
informed by the causal assumptions of the intervention
and interpretation of context, implementation and
mechanisms of implementation. This process evaluation
model and the theories underpinning the intervention
(experiential learning theories and the transtheoretical
change cycle [34]) guided the aims of the evaluation
study.
Aims and objectives
Aims
The aim of this study is to evaluate the feasibility of inte-
grating ADNAT into paediatric diabetes care with re-
spect to:
(i) Resources and processes that influence the clinical
implementation of ADNAT
(ii)Methodological issues in preparation for a large scale
study
Feasibility objectives
The objectives of this study are to evaluate:
1. ADNAT’s clinical utility in relation to delivery of
paediatric diabetes care
2. How paediatric diabetes health care staff (nurses,
doctors, psychologists and dieticians) perceive use of
ADNAT within the context of their clinical
experiences
3. Key methodological issues that influence sustainability
and best practice
Methods
The objectives were defined more specifically using the
RE-AIM framework [35], as recommended in MRC
guidance. RE-AIM stands for reach, effectiveness, adop-
tion, implementation and maintenance and included the
following:
1. Reach: we assessed the number of participants
recruited and retained and response rates to
ADNAT, i.e. number completed divided by total
number of recruits. Data were obtained from
research nurses’ and patients’ ADNAT (monthly)
data returns.
2. Effectiveness (potential and perceived): we used
NPDA data to assess (pre-study) the functional
status of each site, a survey to measure site and
practitioners’ views on ADNAT’s effectiveness and
collected pre/post-glycated haemoglobin (HbA1c)
data, taken from patients’ notes by the research
nurses, to determine any potential changes in
patients’ glycaemic control.
3. Adoption: we carried out a survey to assess system
and information quality, accessibility, social norms,
data protection and intention of PDUs to use
ADNAT in the future. Focus group interviews
explored resources needed to set up and sustain use
of ADNAT, staff perceptions of factors affecting
adoption and their training needs.
4. Implementation/maintenance: the survey and focus
groups also explored staff responses to working with
ADNAT including perceived value and health
improvement outcomes, and the focus group
interviews looked at facilitators and barriers to use.
The study was conducted between January 2013 and
February 2015. Setup and delivery was supported by the
Cheshire and Merseyside Children’s Clinical Research
Network (CRN). This support included access to the
NIHR CRN-funded research nurses in post at the three
NHS Trust sites which were selected based on geog-
raphy and positive responses to invitation letters. The
UK National Research Ethics Service (NRES) defined the
study as a service evaluation [36] (see Additional file 1
for the copy of the letter). Approvals from the R&D de-
partments at the three sites were received. The research
team had no access to identifiable information for any
patient consenting/assenting to participate.
Participants
The participants were young people with type 1 diabetes
aged 12–18 years.
Respondents, sites and support
Respondents were health professional members of the
diabetes teams including paediatric diabetes specialist:
nurses, doctors, dieticians and psychologists at three
paediatric diabetes centres in the North West of
England. These three sites allowed the study to capture
diversity of feedback data and ensured adequate repre-
sentation based on information provided in the 2013–
2014 NPDA data (see Table 3). The approach to the
implementation of ADNAT was tailored according to
team dynamics but each site had a named research nurse
for the study, and all members of the team were trained
informally by HC to use ADNAT. On-going support was
provided by the on-site research nurses and by the
ADNAT technologist via email. Each site commenced at
a different time point with site 1 starting in March 2013,
site 2 in June 2013 and site 3 in February 2014.
Recruitment
We planned to recruit a minimum of 80 patients attend-
ing clinic appointments over an 18-month period. Re-
cruitment was undertaken by the research nurses
working in liaison with the diabetes teams to identify
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young people who met the inclusion/exclusion criteria,
as shown in Table 1. A letter of explanation and the
study information sheet were posted to eligible young
people who were later targeted at their clinic appoint-
ments. If they agreed to participate, those under 16 gave
signed assent, whilst those over 16 years provided in-
formed consent. Proxy consent of parents/guardians of
young people under 16 was also obtained. All informa-
tion sheets and consent forms were produced in age-
and-stage-of-development appropriate formats and were
checked before use by an audit team at one of the par-
ticipating sites. Copies of the signed assent/consent
documentation were given to the young people and,
where appropriate, their parent/guardian for their re-
cords; the original copy was filed in participants’ medical
notes, and copies were kept in the site study files held
by the research nurses.
Delivery of ADNAT
Participants were provided by the research nurses
with username and password access to the ADNAT
App, alongside their usual standard care based on the
BPT [8] criteria (3-monthly follow-up including
HbA1c, and tailored self-care education; annual review
of body mass index, blood pressure check and screen-
ing for eye and kidney problems from age 12, plus
psychological assessment). The ADNAT App was
accessed through the Internet using a PC, laptop or
mobile technological devices including participants’
mobile phones or tablets. They could choose where
to complete it: at home and/or in clinic on their own
smart phones or using iPads loaned to them by the
research nurses. All participants were followed up at
their diabetes outpatient clinics or at a home visit. In
both cases, the ADNAT outcome data was used to
guide their health care plans. Those who successfully
completed and submitted their ADNAT question-
naires were called the ‘completers’, whilst those who
chose not to submit were called the ‘non-completers’
and were used as the comparative group.
Quantitative feasibility outcome data
A range of feasibility outcomes were measured including:
 ADNAT data to measure reach in terms of response
rates across the PDUs. All data, which was
automatically downloaded onto a secure central
database, were encrypted to ensure anonymity. Data
included number of participants recruited and
retained and response rates to ADNAT and ADNAT
NARs for self-care and psycho-social health.
 National Paediatric Diabetes Audit (NPDA) data [4]
to assess the functional status (effectiveness) of each
site.
 Glycaemic control to compare potential effectiveness
pre/post-intervention levels of glycaemic control
using baseline HbA1c levels (means/standard
deviations over previous 12 months), and 6-month
post-ADNAT levels obtained from patients’ clinical
notes by the research nurses.
 A 67-item survey to collect information on
perceived effectiveness, adoption, implementation
and maintenance. Adapted from a validated survey
developed by Okazaki et al [37], it has seven
domains including system and information quality,
accessibility, perceived value, data protection, health
improvement, subjective norms and intention to use
in the future. We also included an open-ended
question at the end asking if there was anything they
would change. The survey was facilitated by the
Audit Department at one of the participating sites
using SNAP software (http://www.snapsurveys.com/)
and was pilot tested by two researchers. It was sent
out by the Audit Department via an email link to all
respondents. Responses were returned directly to
the Audit Department where analysis of the data
was completed using SNAP software.
Qualitative process evaluation data
Three focus groups were run at the end of the study
period, one at each of the three sites. All respondents
were invited to participate, and they were sent informa-
tion sheets and an interview schedule prior to the meet-
ings. The schedule was informed by the RE-AIM
domains. It aimed to evaluate training needs, staff per-
ceptions of facilitators and barriers to using ADNAT,
and staff responses to working with ADNAT including
perceived value and perceived health improvement out-
comes. Consent forms, prior to participation, were
signed for tape-recording the interviews.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Type 1 diabetes (T1D) ≥3 months
post diagnosis
Co-existing pathology, e.g. cystic
fibrosis
Aged 12–18 years inclusive In receipt of prescribed medication
likely to affect glycaemic control,
e.g. systemic steroids
Able to give assent <16 years of
age and informed consent >16 years
Have a diagnosed psychological or
psychiatric disorder(s) that requires
specialist treatment
Have parental/guardian consent for
young people <16 years
Able to complete ADNAT
Have Internet access at home,
school, hospital, public library or via
mobile technology
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Progression criteria
We specified a priori progression criteria that should be
met in order for continuation to the main study. These
included the following: that recruitment to the study
should be ≥30% of the PDUs’ eligible 12–18 years popu-
lations attending clinic, that there should be no deterior-
ation in mean HbA1c levels at 6 months in participants
and that diabetes teams should report positive feedback
on ADNAT’s perceived effectiveness including system
and information quality and accessibility and be tailoring
ADNAT to meet their site needs.
Data analysis
The encrypted quantitative ADNAT data were collated,
coded and analysed using R or SPSS. All quantitative
data taken from the ADNAT questionnaires were
checked for missing or unusual values and for internal
consistency of the scoring items. Participant glycaemic
control (HbA1C) was monitored pre and post use of
ADNAT at each site and across all sites using summary
statistics for completers and non-completers. Analysis of
covariance was performed with post-HbA1C as the
dependent variable and baseline HbA1C, completer sta-
tus and site as the independent variables to assess
whether any preliminary change in HbA1C levels was ap-
parent. Correlations between high/moderate self-care
needs (based on the self-care NAR) and poor/moderate
levels of (pre-baseline and at 6 months) HbA1c were
analysed using Spearman’s rho statistic [38].
Qualitative data were analysed using an inductive the-
matic content analysis, assisted by QSR NVivo software.
First, an evolving set of themes was created and linked
to respondents’ ‘quotes’. These themes were then cate-
gorised within the RE-AIM domains. To assure trust-
worthiness of the analysis, respondent validation was
used by cross-checking findings with respondents and
triangulating it with the quantitative outcomes.
Results
Data from recruitment of patients, the NPDA, the sur-
vey and focus groups comprise the results of the study.
The RE-AIM domains are used to present both the
quantitative and the qualitative data.
Comparison of ADNAT completers versus non-completers
Reach
Table 2 shows recruitment rates and participant charac-
teristic data. We planned to recruit a minimum of 80 pa-
tients and we recruited 89 in total, with an uptake of
65–70% of those who were screened as eligible to par-
ticipate. The graph in Additional file 2 shows that actual
recruitment rates were above our monthly anticipated
target rates. Of those recruited, there were twice as
many females to males and the withdrawal rate was low
at 4.5% (n = 4). Reasons for withdrawal included patient
transfer to other areas (n = 1) and not wanting to con-
tinue with the study (n = 3). Forty-four young people
(49.4%) submitted their completed ADNAT question-
naires. There were more female than male completers
and non-completers (ratio ~1 male to 2 females), and
their average age was 14.3 years compared to 14.5 years
for the non-completers. Forty-eight of the young people
were aged 11–14 years (25 completers, 23 non-
completers), and 41 were aged between 15 and 18 years
(19 completers, 22 non-completers).
Effectiveness (potential): glycaemic control
Data in Table 3 are taken from the 2013/14 NPDA [4]. It
shows disparity between the sites for the percentage of
young people who have a mean HbA1c of the recom-
mended level of less than 58 mmol/mol (range 8.1–
26.5%), with the mean (range 65.5–78.7 mmol/mol) and
median values (range 64–74 mmol/mol) for all sites
above the recommended level. The NPDA ascribes such
variability (despite statistical adjustments for known
Table 2 Participant (patient) characteristics
Site 1 2 3 Combined
No. recruited 28 26 35 89
Male/female ratio 8:20 10:16 12:23 30:59
Withdrawals (%) 0 2 (7.7%) 2 (5.7%) 4 (4.5%)
ADNAT completers
N (%a) 13 (46.4%) 18 (69.2%) 13 (37.1%) 44 (49.4%)
Male/female ratio 4:9 8:10 3:10 15:29
Mean age, years (range) 14.3 (12–16) 14.4 (12–17) 14.3 (12–16) 14.3
ADNAT non-completers
N (%a) 15 (53.6%) 8 (30.8%) 22 (62.9%) 45 (50.6%)
Male/female ratio 4:11 2:6 9:13 1:2
Mean age, years (range) 14.7 (11–17) 15.3 (12–18) 14.1 (12–17) 14.5
aPercentage of the number recruited
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confounding influences, such as ethnicity, social
deprivation, gender, age and diabetes duration) to differ-
ences in service provision and delivery which has par-
ticular relevance for this study. In relation to this, care
process records, which are used to monitor diabetes
management and detect long-term complications at the
earliest treatable stage, were also significantly different
in terms of incomplete records (range 25.4–69.1%),
again highlighting disparity between the three sites. Of
note is the fact that the two with poorer HbA1c audit re-
sults (sites 1 and 3) had interruptions in team function-
ing during the study period due to staff changes and/or
long-term staff absences owing to sickness.
Table 4 shows the glycaemic control data pre- and
6 months post-ADNAT for the completers versus the
non-completers. For both groups, subject-specific profile
plots (not shown) and the range of pre- and post-HbA1C
levels indicated that the young people had very different
pre-glucose levels and variable rates of change leading to
their post-HbA1C levels. Overall, summarising across all
three sites, there was a non-significant reduction in the
post-ADNAT mean and median HbA1c levels for the
completers versus a non-significant increase in the mean
and median levels for the non-completers. The mean
HbA1C levels are illustrated in Fig. 1 and suggest a po-
tential decreasing trend in HbA1C for ADNAT com-
pleters. This trend is encouraging given that our
progression criteria defined ‘no deterioration in HbA1c’
as the outcome at 6 months.
The results of the analysis of covariance (ANCOVA),
presented in Table 5, show how post-ADNAT mean
HbA1C levels changed after adjustment for pre-HbA1C,
completer status and site. In general, the model ex-
plained a reasonable amount of the overall variability in
post-HbA1C levels with a R
2 value of 0.52. Only pre-
HbA1C mean level was a strong predictor of post-HbA1C
mean level (p < 0.001), which is to be expected since the
two measures are correlated. On average, post-HbA1C
levels increased by 0.71 mmol/mol for each unit increase
in baseline HbA1C. The completer status variable
reached borderline significance (-5.42, 95% confidence
interval −11.48, 0.64), indicating that on average, com-
pleters had a post-ADNAT mean HbA1C level of
5.42 mmol/mol lower than non-completers. Mean differ-
ences between site 2 and site 3 compared to site 1 indi-
cated a lower average post-HbA1C mean difference by
1.75 mmol/mol at site 2, and a higher average mean dif-
ference by 1.50 mmol/mol at site 3, compared to site 1,
after adjusting for baseline HbA1C and completer status,
but these differences were non-significant. Please note
that the results from the above model should be inter-
preted with caution due to the small numbers at each
site.
Figure 2 shows a scatter plot of the correlation be-
tween HbA1C levels and self-care scores. The Spearman
rho coefficient is 0.46 suggesting a good moderate cor-
relation with higher (worse) self-care scores indicating
higher HbA1C levels overall. Only at one site was very
little correlation observed due to several outlying young
people with high HbA1C levels but generally lower self-
care scores.
All questions comprising the self-care score are listed
in Table 6 together with the number of children and per-
centage scoring green, amber and red at each site using
Table 3 Summary outcome data for the three study sites taken from the 2013–2014 National Paediatric Diabetes Audit
Site 1 2 3
Total number of patients (aged 10–18 years) 248 (211) 110 (98) 121 (99)
HbA1c <58 mmol/mol (normal HbA1c range = 20–41 mmol/mol) 16.6% 26.5% 8.1%
Mean HbA1c 72.4 65.5 78.7
Median HbA1c 69.0 64 74.0
% incomplete records of care processes (except HbA1c) 25.4% 40.7% 69.1%
Table 4 Participant (patient) glycaemic control data pre/post-ADNAT
Summary measure Site 1 Site 2 Site 3 All sites
Completers
Pre-mean HbA1c mmol/mol (sd) 73.1(22.4) 64.8(15.9) 74.6(14.8) 70.2(18.0)
Post-mean HbA1c (mmol/mol) (sd) 63.1(12.6) 64.7(9.8) 75.9(21.7) 67.7(16.0)
Number of pre ADNAT 13 18 13 44
Non-completers
Pre-mean HbA1c mmol/mol (sd) 78.9(21.0) 61.9(13.2) 68.8(18.8) 71.0(19.4)
Post-mean HbA1c (mmol/mol) (sd) 81.4(23.6) 63.7(13.2) 71.0(20.5) 73.4(21.3)
Number of pre ADNAT 15 8 22 45
sd stands for standard deviation
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the ADNAT scoring algorithm. Examples of the response
categories, comprising green, amber and red coding, are
also given for a selection of the items. The table indicates
that a large proportion of young people were scoring
green for each item, indicating reasonable management,
but box plots by item and site (not shown) suggested that
there was variability across items and sites and that it was
not necessarily the same group of young people scoring
green across all items.
Survey
Eleven people (two males, nine females) out of 14
completed and submitted the survey. They included
seven nurses, one doctor, two dieticians and one re-
search nurse. When asked about years worked in
paediatrics, two had worked for five or less years, two
for 6–10 years, five for 11–20 years and two for 21–
25 years. Two people had a recognised adult teaching
certificate (English National Board 998 Adult Teach-
ing and Assessing course), but no one had a paediat-
ric teaching qualification.
Adoption
Table 7 shows responses to statements relating to adop-
tion of ADNAT. Given the ad hoc nature of the scales
used, single item responses are reported (as opposed to
scale-scores) which cover the following areas:
 Information and system quality: the majority of
respondents (n = 7–9) gave a positive response to
the five statements relating to information quality,
suggesting confidence in ADNAT. However, there
Fig. 1 Plot of pre- and post-mean HbA1C levels for completers and non-completers
Table 5 ANCOVA regression analysis on post-HbA1C levels
Variablea Estimate Std. error 95% confidence interval
Intercept 22.79 6.31 10.42, 35.16
Pre-HbA1c 0.71 0.08 0.55, 0.87
Completers −5.42 3.09 −11.48, 0.64
Site 2 −1.75 4.11 −9.80, 6.30
Site 3 1.50 3.92 −6.18, 9.18
aReference categories are non-completers and site 1
Fig. 2 Scatterplot of HbA1C level and self-care total score at 6 months
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was uncertainty for four participants in relation to
ADNAT being sufficiently complete to meet their
patients’ needs. Overall, the majority of participants
strongly agreed or agreed with the 13 statements
relating to system quality, but some ambivalence was
expressed in relation to ADNAT launching and
running quickly and not crashing.
 Intention to use ADNAT in the future, accessibility
and capability with technology: ten respondents said
they intended to use ADNAT when it is available at
their work place. However, the majority (n = 9)
indicated that accessing Wi-Fi is a problem in their
work place, and four people felt that their workplace
is not good in the way it uses technology. Nine
Table 6 Summary of item scoring classifications of 20 ADNAT self-care questions with examples of some of the shorter range of re-
sponses (in brackets)
Scoring algorithm summaries
count (%)
Domain Item no. Question (responses comprising green/amber/red) Green Amber Red
Physical activity 16 How many hours of pulse-raising exercise or physical activity did you do last
week?
(7-8 hours or more than 8 hours/3-4 hours or 5-6 hours/Less than 1 hour or
1-2 hours)
8 (18%) 19 (42%) 18 (40%)
18 What stops or prevents you from starting to do exercise or physical activity? 26 (58%) 2 (4%) 17 (38%)
21 What makes it difficult to manage your blood glucose levels when exercising
or doing physical activity?
19 (42%) 9 (20%) 17 (38%)
22 What usually happens to your blood glucose levels when you do exercise or
physical activity?
23 (51%) 15 (33%) 7 (16%)
Eating 34 Do you eat fruit and/or vegetables?
(Yes usually every day/Sometimes but not every day/No or very rarely)
28 (62%) 16 (36%) 1 (2%)
35 How many times a week do you eat treats, such as sweets, chocolate, fast
food, takeaways?
(1-2 or Less than once per week/3-4 days/Every day or 5-6 days)
20 (44%) 15 (33%) 10 (22%)
38 Which statement best describes you? (diet control) 34 (76%) 11 (24%) 0 (0%)
41 Which statement most applies to you? (carbohydrate calculation) 42 (93%) 0 (0%) 3 (7%)
45 Are you happy with your weight?
(Happy with weight and never tried to gain or lose/Happy with weight but
have tried to gain or lose/Not happy with weight or Prefer not to say)
19 (42%) 12 (27%) 14 (31%)
Monitoring blood glucose 50 How often do you normally test your blood glucose in a day?
(Once or twice or 3-5 times or More than 5 times/It varies a lot depending
on where I am or what I’m doing/I don’t usually test my blood at all)
35 (78%) 10 (22%) 0 (0%)
51 What motivates you to test your blood glucose? 40 (89%) 5 (11%) 0 (0%)
53 How would you describe your blood glucose results?
(They are generally within the recommended levels/They always go up and
down/They are usually high or They are usually low or I’m not sure or I don’t
know because I don’t usually test my blood)
20 (44%) 21 (4%) 4 (9%)
57/62 How often do you have hypos/low blood glucose (less than 4 mmols/l)?
Have you been unconscious from hypoglycaemia in the last 12 months?
6 (13%) 33 (73%) 6 (13%)
66/71 How often do you have high blood glucose (more than 10 mmols/l)?
Have you had diabetic ketoacidosis in the last 12 months (not including at
diagnosis)?
24 (53%) 5 (11%) 16 (36%)
76 What would you like your HbA1c to be? 39 (87%) 0 (0%) 6 (13%)
Medication taking 80 What motivates you to do your injections or to give insulin through your
pump?
30 (67%) 14 (31%) 1 (2%)
Living with diabetes 92 What would you do if you were ill with an infection (e.g. sickness/flu) and it
made your blood glucose high?
38 (84%) 1 (2%) 6 (13%)
94 You are staying over at your friend’s house. Which of the following would
you do?
42 (93%) 1 (2%) 2 (4%)
111 You are going to a party one Friday night with your friends and you know
that they will be drinking alcohol.
Which statement best describes what you would do?
37 (84%) 4 (9%) 3 (7%)
112 Which statement best describes you? (diabetes and life) 13 (30%) 24 (54%) 7 (16%)
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reported that patients had completed ADNAT at home
and five in clinic. All respondents felt that ADNAT was
secure with regard to data protection.When asked
about using technology in clinical practice, nine
respondents reported capability with computers, tablets
and mobile devices; the remaining two were
ambivalent. Nine people regarded technology to
be an important element of their patients’ education.
 Social norms (not shown in Table 7): when asked to
give an opinion on whether their National Children
and Young Peoples’ Diabetes Network, their
managers, their colleagues, and their patients and
families would think they should be using ADNAT,
all participants (n = 11) responded positively to the
Network and patients and families options, and
seven positively responded to the managers and
colleagues options.
Implementation/maintenance
Table 8 summarises survey responses to questions relat-
ing to implementation and maintenance of ADNAT
which included the following:
Table 7 Responses to statements concerning system and information quality and intention to use ADNAT in the future
Information quality: the information I obtained from ADNAT Yes No Not sure
Was easy to understand 9 2
Was easy to interpret 8 1 2
Included all necessary assessments 9 2
Was sufficiently complete to meet my patients’ needs 7 4
Had sufficient breadth and depth for my patients 8 1 2
Total 41 2 12
System quality Strongly
disagree
Disagree Neither agree
nor disagree
Agree Strongly
agree
Not applicable
ADNAT is easy to use 1 6 3 1
ADNAT is equipped with useful features and functions 1 7 2 1
ADNAT is easy to complete 6 3 2
ADNAT is always available to use 1 3 5 1 1
ADNAT launches and runs right away 2 5 2 1 1
ADNAT does not crash 1 5 3 1 1
ADNAT does not freeze after entering or retrieving information 1 4 4 1 1
The commands of ADNAT are well depicted by symbols and buttons 3 5 2 1
The layout of ADNAT is clear and consistent 1 6 3 1
The design of ADNAT is easy to use or operate 1 1 5 3 1
The Technologist showed a sincere interest in solving my problems 2 3 1 5
The Technologist gave me personal attention 3 2 1 5
The Technologist was dependable 3 2 1 5
Total 6 32 56 23 26
Intention to use in the future
Technology is an important element of my patients’ education 2 3 6
Without Technology I would be unable to do my work 3 2 6
Technology makes my work more enjoyable 1 7 1 2
My workplace is not good in the way it uses Technology 1 2 4 2 2
With Technology I interact more with my patients 3 2 4 2
I find using computers difficult 6 3 2
I find using technological devices difficult e.g. mobile phones, iPads 6 3 2
Getting access to Wifi is a problem in my work place 1 1 2 7
Technology makes my work easier 4 5 2
It would be good if Technology was used more 4 4 3
Total 14 13 32 28 23 0
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 Perceived value: overall, respondents judged ADNAT
to be effective, practical, useful and efficient, with
nobody judging it to be poor. In relation to factors
that influenced its value to patients, respondents were
unsure about gender, insulin regimen and hospital
admissions, but more confident with regard to
parental support, age and previous diabetes education.
 Health improvement outcomes: statements here were
based on the transtheoretical change cycle. The
majority of participants indicated that ADNAT had
an effect at each of the eight different stages of the
cycle with the majority indicating that effects
happened sometimes, often or regularly. The ‘not
applicable’ responses came from the research nurse
who was not involved at the clinical level and were
therefore not included in the calculations.
When asked to add any comments about what they
would change about ADNAT (not included in Table 8),
five responses were received including the need for iPads
and improved Wi-Fi access in clinics, access to on-line
reports and inclusion of a section for patients to ask for
immediate feedback/help from the diabetes team.
Focus groups
Each site and participant was coded (based on roles and
numbers) for reference purposes as follows: Paediatric
Diabetes Specialist Nurses (PDSN 1–6), Doctors (Dr
1,2), Researcher (R 1,2), Psychologist (P) and Dietician
(Di). Twelve people in total attended the three groups
(site 1: n = 5, site 2: n = 3, site 3: n = 4) providing a total
of 160 min of recorded conversation. Analysis of the
focus group data produced seven sub-themes which
were aligned to the RE-AIM framework (themes). Find-
ings are presented using anonymised quotes to capture
the essence of the phenomena and are summarised at
the end in Tables 9 and 10 which provide a combined
Table 8 Responses to statements concerning perceived value of ADNAT and health improvement outcomes
Statements Poor Fair Average Good Excellent
Perceived value of ADNAT in relation to
Effectiveness 1 2 8
Practicality 2 4 5
Usefulness 1 8 2
Efficiency 4 6 1
Total 3 11 27 3
The value placed on ADNAT by my patients depended upon
Yes No Not sure
Age 6 1 4
Gender 4 7
Reading and numeracy skills 6 5
Previous diabetes education 6 1 4
Parental support 8 3
Insulin regimen 4 7
Hospital admissions 4 7
No. of contacts with diabetes team 3 2 6
How frequently did ADNAT help your patients in relation to
Never Seldom Sometimes Often Regularly Not applicable
Enlisting help 3 6 1 1
Increasing knowledge about managing diabetes 1 6 2 1 1
Being aware of personal risks 1 8 0 1 1
Understanding benefits of changing behaviour(s) 1 8 1 1
Committing to changing behaviour(s) 1 8 1 1
Developing a plan for changing behaviour(s) 1 1 8 1
Changing behaviour(s) 1 8 1 1
Being aware of relapse 1 1 6 1 1 1
Total 3 9 58 4 8 6
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summary of the quantitative and qualitative data and a
synopsis of practice recommendations.
Adoption themes
 Tension for change
Respondents found ADNAT to be a viable option for
clinical practice and wanted to change the way they en-
gaged with their patients by using technology, recognis-
ing that web-based applications play a crucial role in
adolescent life. They perceived technology as a way of
overcoming communication barriers, as this nurse
commented,
I remember being quite impressed at what they were
saying they didn’t know. So it seems to get past that
barrier when it is face to face. They are more likely to
be honest even though they know we’re going to see it
(PDSN4).
 System fit
The three sites all felt that ADNAT fit within their
teams’ values and goals, with participants suggesting that
it could standardise educational assessment allowing for
comparisons between PDUs. As a policy driver, the BPT
enhanced motivation to use ADNAT, linking it to the
education criteria. Other respondents agreed with this
thinking suggesting that it also met with the peer review
process but questioned its practical potential as an audit
tool given that it assesses those aged 12–18 years only
making it ‘difficult to draw any conclusions’ (Dr1).
 Organisational working
Operationally, decision-making regarding how to
implement ADNAT was devolved to the teams to see
what emerged. Two different methods were used: in-
dividual nurses reviewing their own patient returns
versus using a generic email for all returned
Table 9 Summary of quantitative and qualitative data for feasibility outcomes
RE-AIM themes Outcomes (patients) Survey (diabetes team) Focus groups (diabetes team)
Reach • Uptake better than expected (n = 89)
• Twice as many females to males
recruited
• Low accrual rates (n = 4)
• Response rates 49.4%
• Average age of completers and non-
completers 14.3/14.5 years respectively
• More female than male completers:
ratio ~2:1
• All reported technological capability in
clinical practice
• Some ambivalence re: using
technology in patients’ education
• No paediatric teaching qualifications
• Ideal time to integrate ADNAT into
clinical practice
• Offers a technological approach to
care in line with policy and young
peoples’ needs
• Fits within BPT’s education criterion/
peer review process.
• Potential as an audit tool questioned
given its focus on 12–18 years only
• Training to use activity learning to
support a team approach and include
expert users of ADNAT
Effectiveness (potential
and perceived)
• Completers—post-ADNAT mean
HbA1C level 5.42 mmol/mol’s lower than
non-completers at 6 months
• ADNAT judged to be effective at each
of the 8 different stages of the
transtheoretical change cycle
• ADNAT’s system and information
quality judged as good
• ADNAT judged to be effective,
practical, useful and efficient
• Value to patients perceived to be
linked to parental support, age and
previous diabetes education
• Time between patients’ completions
and reviews with practitioners in clinic/
home critical to effectiveness
• ADNAT perceived to promote
behaviour change
• Primary outcomes to include
glycaemic control and quality of life,
with qualitative data to illuminate wider
effects of education
Adoption • Majority of patients completed ADNAT
in clinic
• All felt that patients, their families and
the Diabetes Network would want
ADNAT to be used
• Majority intend to use ADNAT in the
future
• Lead clinician support essential
• Requires a team approach to
implementation
• Needs to be tailored to fit each team
• Scoring, traffic light feedback,
drop-down menus and navigation
commands support tailored health care
planning but some concern re: patients’
responses to traffic light system
Implementation/
maintenance
• Access to Wi-Fi in clinics poor/
negligible
• No data protection issues reported
• Need for:
– Improved Wi-Fi access and IPads
– Section for patients to ask for
immediate feedback/help from diabetes
teams
– Access to short on-line patient reports
• Access to on-line technical support
needed
• Use of Ipads with SIM cards to
overcome Wi-Fi problems in clinics
• To secure clinical feasibility:
– Home completions prior to clinic visits
– Consents taken in clinic
– Instructions sent in appointment letters
– Automatic text reminders
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questionnaires which was reviewed by one PDSN
only. For the former, choice of treatment was deter-
mined by the individual nurses but they also dis-
cussed their approaches within their teams. For the
latter, the PDSN identified urgent cases, i.e. red traffic
light returns for discussion at team meetings. Both
approaches therefore embraced working as a team, as
the following quote highlights,
We did bring the red ones to the team meeting and
there were actions..generated from it, and we did
implement those actions. I think the ones that came
through green reinforced what we felt but it was good
to get the teenagers’ perspectives married up with
ours (PDSN2).
 Team working
Team capacity varied owing to sickness absence and/
or new staff starting. Site 2 was not affected by these
problems and had an established team. It was notable
that this site had the best 2013/2014 audit returns in
relation to glycaemic control (as highlighted in Table 3)
and also the best ADNAT return rates (69.2%), com-
pared with the other two sites (46.4 and 37.1%). With
regard to team working, participants commented on
how ADNAT encouraged a standardised approach
which supported consistency in the messages given to
patients. They argued that integrating ADNAT into
their team work would normalise its use, although lack
of time, given the current politically driven changes,
had impacted upon feelings of being in control. Re-
spondents talked about ‘time constraints’, ‘feeling too
busy’ and ‘a continual focus on problems’. Receptivity
for change therefore varied across the sites although
respondents felt that ADNAT had the potential to
drive change.
Implementation/maintenance themes
 Time
The time taken for patients to complete ADNAT was
discussed given the large number of questions to be an-
swered, but two respondents had asked patients for their
perspectives and both reported positive responses,
I asked quite a few of them, was it a waste of 30
minutes of their life and they all said ‘no’ they felt it
was useful that they’d done it, and many of them said
it made them think… (Dr2)
..a lot of them came back and said it was a good use
of their time and gave them that refreshment of the
advice that we gave them previously (PDSN6).
For the practitioners, the time taken to review patients’
outcome results was helped by ADNAT’s scoring and
traffic light feedback systems, alongside the drop-down
menus and navigation commands to allow selection of
scoring questions only and/or questions relating to the
different domains. However, when asked whether they
felt the traffic light system was good for the children,
there was a mixed response. It was viewed as both a fa-
cilitator and a barrier, with the barrier relating to its po-
tential to raise young peoples’ anxiety.
 Embedding ADNAT into practice
There were mixed responses with regard to where
ADNAT should be completed. Location was seen as
important affecting both uptake and practitioner feed-
back to patients. Home completions brought prob-
lems in relation to patients being willing to complete
it once they left clinic, and time between completion
Table 10 Practice implications
Reach • Lead clinician’s support required alongside a team approach to foster integration, normalisation and
consistency in the messages given to patients and their carers
Effectiveness (potential and perceived) • Time between patients’ completions and clinic reviews critical to success
Adoption • Access to technical support and iPads with SIM cards to overcome Wi-Fi problems in clinics
• Staff training: use an activity style of learning and limit to a maximum of 4 h to support team working
and the tailoring of ADNAT for each team
• Include expert patients in the training to provide insights into their ADNAT experiences to support
connections between theory and practice
Implementation/maintenance: • Consents to be taken in clinic, followed by instructions at a later date in patients’ appointment letters
• ADNAT to be completed at home prior to their clinic consultation, supported by automatic text reminders
• Short time span needed between patients’ completions of ADNAT and follow-up reviews
ADNAT requires:
• Section for patients to ask for immediate feedback/help from diabetes teams
• Short on-line reports, i.e. ADNAT profiles for each patient for practitioners
• Less threatening feedback response for patients to overcome potential negative responses to the (red)
traffic light feedback system
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and feedback was deemed important, as the following
quote highlights,
Because they did it at home and sometimes then a
week after their previous clinic appointment, then it
would be reviewing it again much later. …and actually
they couldn’t remember the results (PDSN4)
Theoretically, completions in clinic prior to their con-
sultation were thought beneficial, but practically, this
was not an option given time limitations. Home visits
were appropriate for two of the sites, but at the third
site, home visits were being discouraged by manage-
ment. These comments highlighted a barrier to embed-
ding ADNAT into practice. When questioned about how
this could be overcome, integrating ADNAT into pa-
tients’ health care plans was seen as a viable option, with
patients completing ADNAT prior to their next clinic
appointment at home. Suggestions included gaining con-
sents in clinic and sending instructions on how to
complete ADNAT with their clinic appointment letters,
followed by text reminders. The role of the lead clinician
was seen as crucial for embedding ADNAT into routine
practice, alongside mandating its use through, for ex-
ample, including it in the BPT criteria. Tailoring ADNAT
to fit each site was seen as important, paying attention
to the whole team being involved. To meet this goal,
training (up to a maximum of 4 h) was considered es-
sential. Web-based instruction was not popular given
the need for self-motivation and personal time, but face-
to-face training was deemed superior in that it would,
..help to promote the team aspect of it because
discussion could be had about how to make it
cohesive as a team (PDSN4).
Another suggestion was to include previous users of
ADNAT, i.e. expert patients in the training programme.
 Linkages
Respondents felt that ADNAT mapped on to what
they are aiming to achieve in clinic including getting pa-
tients to “create (their own) agendas and identify things”
(P). Other respondents felt that it provided the link be-
tween all the different components of diabetes self-
management commenting that ADNAT got patients
“thinking about aspects of the condition which they
might normally not really think about” (PDSN 3). There
were comments that in clinic, the focus tends to be on
blood glucose and insulin doses whilst ADNAT pro-
moted reflection on all aspects of their diabetes, includ-
ing their feelings. One person summarised ADNAT’s
perceived value in the following way,
the opportunity for self-evaluation of learning, reflection,
and for young people to actually get feedback on what
they know, and also for the teams to have feedback on
what they know as young people (Di).
This process of self-evaluation was a strong theme
throughout the focus groups with one nurse comment-
ing that ADNAT, “…reminded them (patients) about the
right ways to manage their diabetes” (PDSN6). There
was an agreement that ADNAT promotes behaviour
change, and in terms of why it is effective, one person
summarised her opinion by saying that,
It gives them (patients) a chance to identify. They’re
doing the identifying, possibly prioritising things for
themselves …and if it has come from them, then they
are much more likely to engage in conversations
about what could be done differently…. (P)
Respondents questioned the traditional (misplaced)
focus on glycaemic control with one person stating that
education is more about quality of life at this age and
being able to ‘… get a balance between their diabetes
and being a teenager…’ (PDSN4). This point was agreed
by others who felt that a single educational intervention
is not going to impact upon glycaemic control because
there are ‘an awful lot of things that affect someone’s
HbA1c’ (Dr.2). Education was seen as beneficial in other
ways including improving quality of life and self-care
processes, and the example of carrying glucose to treat
hypoglycaemia was used to highlight this point.
Having open-ended text responses at the end of each
question was seen as important, because it allowed pa-
tients to express their feelings of knowing more and be-
ing in control. This concept of ‘control’ was an
important theme, with ADNAT being viewed as a way of
accessing patients’ needs without removing their sense
of control, as the following quote highlights,
..it might be a question that they (patients) might not
have thought about, but felt a bit embarrassed, or
thought well, I shouldn’t think like that, or maybe
other people don’t feel or think like that, I should
know that. (PDSN3)
Accessing patients’ needs meant that the teams could
tailor conversations with their patients, focusing on their
raised self-awareness with regard to what they did and
did not know, providing a base on which to progress
joint health care planning.
Combining the data
We used the RE-AIM framework to combine the data
from recruitment of patients, the NPDA, the survey and
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the focus groups. This summary of the quantitative re-
sults and the qualitative findings is provided in Table 9.
We also identified the main points raised for how best
to integrate ADNAT into clinical practice (summarised
in Table 10).
Discussion
This study aimed to evaluate the feasibility of integrat-
ing ADNAT into paediatric diabetes care focusing pri-
marily upon resources and processes that influenced its
implementation taking into account context and per-
ceived impact. We met each of our progression criteria,
recruiting over 65–70% of those screened as eligible to
take part; there was no deterioration in mean HbA1c
levels at 6 months; and diabetes teams reported positive
feedback on ADNAT’s perceived effectiveness and tai-
lored the use of ADNAT within their clinics to meet
their site needs.
The study also aimed to determine methodological
recommendations for a future large-scale study. Its
strength lies in its mixed methods design and the fact
that there was overlap between the different data sets
which supports the findings and helps to explain the
feasibility outcomes. The summary of the quantitative
results and the qualitative findings in Table 9 shows that
from a quantitative (reach and potential and perceived
effectiveness) outcome perspective, ADNAT met the
proposed mechanisms of action and progression criteria
from a staff perspective. The survey and qualitative find-
ings indicate that ADNAT was acceptable to the diabetes
teams. However, these results need to be interpreted
with caution due to the study design and the associated
confounding factors.
Methodological implications: strengths and
limitations
A limitation of this study is the small number of sites,
participants and respondents involved, alongside the
non-randomisation to treatment. Both of these limita-
tions raise statistical issues concerning the accuracy of
the outcome data. Differences in characteristics between
those patients who chose to complete ADNAT com-
pared to the non-completers are unknown, and it can be
argued that the former group may be more compliant
generally with regard to their diabetes self-care when
compared to the latter group. However, this potential
difference was accounted for by controlling for HbA1c
levels at baseline. Findings therefore provided an insight
into ADNAT’s potential in relation to glycaemic control
(HbA1c), particularly for those poorly controlled. How-
ever, it can also be argued that those young people who
completed ADNAT may have wanted a different kind of
management for their diabetes, one that fits more effect-
ively with a digital culture and their learning styles. This
suggests that completers may have been ready to make
changes compared to the non-completers. Reasons why
young people choose to engage or not in using ADNAT
therefore need to be researched to improve future re-
sponse rates.
Questions regarding the number of young people who
completed ADNAT also need to be addressed. Whilst
the percentage of completers (49.4%) is good in terms of
figures quoted for the response rate of the general popu-
lation to web-based surveys (24.8%) [39], it remains
questionable as to how typical the completers were rela-
tive to the non-completers and to those who declined to
participate. It highlights the need to identify ways of en-
gaging more effectively with what is typically a ‘hard to
reach’ population. Systematic reviews [40, 41] suggest
extended timeframes, recruitment techniques suited to
young people and the need to work in close co-
operation with the community.
The study identified the research setting as a mediator
of outcomes making treatment heterogeneity a con-
founding factor. Whilst ADNAT is a standardised inter-
vention, the responses of the teams to the outcomes of
using ADNAT are heterogeneous. This demonstrated a
need to include non-participant clinic observations in a
future study to evaluate what is actually happening in
clinical practice when ADNAT is used. It also validated
the need to research comparative effectiveness of the dif-
ferent research sites by using the historical NPDA data
to provide evidence on the value of different response
options to ADNAT.
Previous research has highlighted the need for adult
diabetes education to have broad patient-based out-
comes and not to be expected to have lasting benefits on
glycaemic control unless it is repeated. The focus group
data reinforced these points highlighting the need to in-
clude other outcomes such as quality of life and patients’
greater self-involvement in their care. Findings from pre-
vious trials of paediatric diabetes education have also af-
firmed this point [15]. Measures of effectiveness
therefore need to include but not be limited to glycaemic
control.
Conclusions
This evaluation study has provided evidence on the
feasibility of using ADNAT in clinical practice and has
demonstrated a number of limitations which have pro-
vided practice and methodological guidance. It has
shown that a randomised design that fits the needs of a
‘hard to reach’ adolescent population is necessary. A
cluster randomised controlled trial that involves sequen-
tial but random rollout of ADNAT over multiple time
periods may the most appropriate and is currently being
considered for the larger study.
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all three sites based on the requirement that appropriate ethical standards were
followed. We therefore used site files, information sheets and consent/assent
forms. Confidentiality and anonymity were maintained by using a coding
system for all participants (allocated by the Research Nurses), and data were
stored in a locked cabinet. The research team had no access to identifiable
information for any patient taking part in the study.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Public Health and Wellbeing, Clatterbridge Hospital,
University of Chester, Clatterbridge Rd, Bebington, Birkenhead, Wirral CH63
4JYL, UK. 2Research Institute for Primary Care & Health Sciences, Keele
University, Keele ST5 5BG, UK. 3Department of Mathematics and Statistics,
University of Lancaster, Lancaster LA1 4YF, UK. 4NIHR Alder Hey Clinical
Research Facility, Alder Hey Children’s NHS Foundation Trust, Eaton Road,
West Derby, Liverpool L12 2AP, UK. 5Department of Public Health and
Wellbeing, University of Chester, Riverside Campus, Castle Drive, Chester CH1
1SL, UK.
Received: 11 July 2016 Accepted: 18 June 2017
References
1. Pawson R. The science of evaluation: a realist manifesto. Los Angeles,
London, New Delhi, Singapore: Sage; 2013.
2. Moore G, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L,
O’Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex
interventions: Medical Research Council guidance. London: MRC Population
Health Science Research Network; 2014.
3. International Diabetes Federation. IDF diabetes. 7th ed. Brussels, Belgium:
International Diabetes Federation; 2015. http://www.diabetesatlas.org.
Accessed 7 Feb 2016.
4. NHS Information Centre for Health and Social Care. National Diabetes
Paediatric Audit Reports. London: Department of Health. Available at: http://
www.rcpch.ac.uk/improving-child-health/quality-improvement-and-clinical-
audit/national-paediatric-diabetes-audit-n-0. Accessed 15 May 2017.
5. Diabetes Control and Complications Trial Research Group (1994) Effect of
intensive diabetes treatment on the development and progression of long
term complications in adolescents with insulin-dependent diabetes mellitus.
Journal of Pediatr. 1994;125:177–188.
6. National Peer Review Programme. National peer review report: paediatric
diabetes services 2013/2014. London: National Peer Review Programme;
2015.
7. Kennedy I. Getting it right for children and young people. Overcoming
cultural barriers in the NHS so as to meet their needs. London: Department
of Health; 2010.
8. Department of Health. Payment by Results team. Payment by results
guidance for 2011-12. London: Department of Health; 2011.
9. Diabetes UK (2014). The cost of diabetes report. In: http://www.diabetes.org.
uk/Documents/Diabetes%20UK%20Cost%20of%20Diabetes%20Report.pdf.
Accessed 7 Feb. 2016.
10. Li et al. Cost-effectiveness of interventions to prevent and control diabetes
mellitus: a systematic review. (2010) Diabetes Care. In: http://stacks.cdc.gov/
view/cdc/7107/. Accessed 7 Feb 2016.
11. Swift P. Diabetes education in children and adolescents. Pediatr Diabetes.
2009;10 Suppl 12:51–7.
12. Waldron S. Education and other interventions for diabetes management in
children and young people: detailed overview of randomised controlled
trials. Diab Care Child Young People. 2012;1(2):73–4.
13. Price KJ, Wales J, Eiser C, Knowles J, Heller S, Freeman J, Brennan A,
McPherson A, Wellington J. Does an intensive self-management structured
education course improve outcomes for children and young people with
type 1 diabetes? The Kids In Control OF Food (KICk-OFF) cluster randomised
controlled trial protocol. BMJ Open. 2013;3:e002429.
14. Murphy HR, Wadham C, Rayman G, Skinner TC. Approaches to integrating
paediatric diabetes care and structured education. Diab Med. 2007;24:1261–8.
15. Chaney D, Coates VE, Shevlin M. Running a complex intervention—lessons
learned. J Diab Nurs. 2010;14:370–9.
Cooper et al. Pilot and Feasibility Studies  (2018) 4:13 Page 16 of 17
16. Hawthorne K, Bennert K, Lowes L, Channon S, Robling M, Gregory JW, on
behalf of the DEPICTED Study team. The experiences of children and their
parents in paediatric diabetes services should inform the development of
communication skills for healthcare staff (the DEPICTED study). Diab Med.
2011;28:1103–8.
17. Kaufman N. Internet and information technology use in treatment of
diabetes. Int J Clin Pract. 2010;64 Suppl 166:41–6.
18. Means B., Toyama Y., Murphy R., Bakia M., Jones K. (2010) Evaluation of
evidence-based practices in online learning. A meta-analysis and review of
online learning studies. In: http://repository.alt.ac.uk/629/1/US_DepEdu_
Final_report_2009.pdf. Accessed 8 Feb 2016.
19. Seidman JJ, Steinwachs D, Rubin H. Design and testing of a tool for
evaluating the quality of diabetes consumer-information web sites. J Med
Internet Res. 2003;5:e30.
20. Bull SS, Gaglio B, McKay HG, et al. Harnessing the potential of the Internet
to promote chronic illness self-management diabetes as an example of
how well we are doing. Chronic Illn. 2005;1:143–55.
21. Pal BR. Social media for diabetes health education—inclusive or exclusive?
Curr Diabetes Rev. 2014;10(5):284–90.
22. Boren SA, Gunlock TL, Peeples MM, Krishna S. Computerized learning
technologies for diabetes: a systematic review. J Diabetes Sci Technol.
2008;2(1):139–46.
23. Bass AM, Farhangian ME, Feldman SR. Internet-based adherence
interventions for treatment of chronic disorders in adolescents. Adolesc
Health Med Ther. 2015;6:91–9.
24. Cooper H, Cooper J, Milton B. Technology-based approaches to patient
education for young people living with diabetes: a systematic literature
review. Ped Diab. 2009;10:474–83.
25. Cooper H, Spencer J, Lancaster J, Titman A, Johnson M, Lwin R, Wheeler S.
Development and psychometric testing of the online Adolescent Diabetes
Needs Assessment Tool (ADNAT). J Adv Nurs. 2014;70(2):454–68.
26. Cooper H, Spencer J, Lancaster J, Johnson M, Lwin R. Perceptions of the
clinical usefulness of the Adolescent Diabetes Needs Assessment Tool
(ADNAT). Diab Care Children Young P26eople. 2013;1(2):55–61.
27. Cooper H, Spencer J, Lancaster J, Titman A, Johnson M, Lwin R, Wheeler S.
(2015) Development and psychometric testing of the online Adolescent
Diabetes Needs Assessment Tool (ADNAT). World Biomed frontiers Obesity
and Diabetes. In: http://biomedfrontiers.org/diabetes-obesity-2015-1-21/.
Accessed 1/3/2016.
28. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M.
Developing and evaluating complex interventions: the new Medical
Research Council guidance. BMJ. 2008;337:979–83.
29. Spencer J, Cooper H, Milton B. A qualitative phenomenological study to
explore the lived experiences of young people (13-16 years) with type 1
diabetes and their parents. Diabetic Med. 2013;30:e17–24.
30. Spencer J, Cooper H. A multidisciplinary paediatric diabetes health care team:
perspectives on adolescent care. Pract Diabetes Int. 2011;28(5):210–4.
31. Spencer J, Cooper H, Milton B. Qualitative studies of type 1 diabetes in
adolescence: a systematic literature review. Ped Diab. 2010;11(5):364–75.
32. Cooper H, Geyer R. Using ‘complexity’ for improving educational research in
health care. Soc Sci Med. 2008;67:177–82.
33. Diabetes NHS. National Paediatric Diabetes Service Improvement Plan
2013-2018. London: Department of Health; 2013.
34. Ruggiero L, Prochaska JO. Readiness for change: application of the
transtheoretical model to diabetes. Diabetes Spectrum. 1993;6:21–60.
35. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of
health promotion interventions: the RE-AIM framework. Am J Public Health.
1999;89(9):1322–7 (www.RE-AIM.org).
36. NRES: Determine whether your study is research. In: http://www.hra.nhs.uk/
research-community/before-you-apply/determine-whether-your-study-is-
research/. Accessed 7 Feb 2016.
37. Okazaki S, Castañeda JA, Sanz S, Henseler J. Factors affecting mobile
diabetes monitoring adoption among physicians: questionnaire study and
path model. J Med Int Res. 2012;14(6):e183.
38. Altman DG. Practical statistics for medical research, London: Chapman and
Hall/CRC; 1991.
39. Penwarden R. (2014) Response rates for online surveys—what numbers
should we be aiming for? In: http://fluidsurveys.com/university/response-
rate-statistics-online-surveys-aiming/. Accessed 7 Feb 2016.
40. Billie B, Adeleine Randell M, Paul C, Chapman K, Twyman L, Bryant J, Brozek I,
Hughes C. Reaching the hard-to-reach: a systematic review of strategies for
improving health and medical research with socially disadvantaged groups.
BMC Med Res Methodol. 2014;14:42.
41. Shaghaghi A, Raj S, Bhopal RS, Aziz SA. Approaches to recruiting ‘hard-to-
reach’ populations into research: a review of the literature. Health Promot
Perspect. 2011;1(2):86–94.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Cooper et al. Pilot and Feasibility Studies  (2018) 4:13 Page 17 of 17
